← All companies

NVCR

NovoCure Limited

NVCR Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$15.32

+0.09 +0.59%

Key statistics

from XBRL data in SEC filings

Market cap

$1.78B

Revenue (TTM)

$699M

Net income (TTM)

-$149M

EPS (TTM)

$-1.30

P/E ratio

—

Dividend yield

—

Free cash flow

-$25.4M

Cash

$93.7M

Total assets

$795M

Gross margin

76.1%

52-week range

$9.82 – $21.45

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) Jul 23, 2026 10-Q Quarter ended 2026-06-30 Jul 23, 2026 8-K Regulation FD disclosure Jun 30, 2026 8-K Regulation FD disclosure Jun 18, 2026 8-K Director or officer change; Shareholder vote results Jun 5, 2026 8-K Results of operations (earnings release) Apr 30, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K/A Director or officer change Apr 24, 2026 8-K Director or officer change Apr 9, 2026 8-K Regulation FD disclosure Mar 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure Feb 24, 2026 8-K Regulation FD disclosure Feb 11, 2026 8-K Regulation FD disclosure Feb 5, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Director or officer change; Regulation FD disclosure Dec 1, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Regulation FD disclosure Sep 15, 2025 8-K Regulation FD disclosure Aug 28, 2025 8-K Results of operations (earnings release) Jul 24, 2025 10-Q Quarter ended 2025-06-30 Jul 24, 2025 8-K Director or officer change; Shareholder vote results Jun 6, 2025 8-K Regulation FD disclosure Jun 2, 2025 8-K Results of operations (earnings release) Apr 24, 2025 10-Q Quarter ended 2025-03-31 Apr 24, 2025 8-K Regulation FD disclosure Apr 22, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K/A Director or officer change Dec 17, 2024 8-K Regulation FD disclosure Dec 2, 2024 8-K Results of operations (earnings release); Director or officer change Oct 30, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Regulation FD disclosure Oct 15, 2024 8-K Director or officer change; Regulation FD disclosure; Other events Sep 3, 2024 10-Q Quarter ended 2024-06-30 Jul 25, 2024 8-K Results of operations (earnings release) Jul 25, 2024 8-K Director or officer change; Shareholder vote results Jun 10, 2024